Sharing a snapshot of some recent biotech-related trades.More importantly, I want to share how I approach these names rather than focusing only on the results.
Right now, I’m mainly focusing on a few core aspects:
Stock selection logic
Is the business real?
Are the financials or balance sheet improving?
Are there clear catalysts (trial data, FDA milestones, partnerships, sector rotation)?
Risk awareness
Which names are purely speculative momentum plays, and which ones are better suited for short-term, controlled trades?
Timing (not guessing)
I rely on volume shifts, price structure, and trend confirmation not headlines alone.
Entry discipline
I try to participate where risk is defined and manageable, instead of chasing extended moves.
Currently, a few friends and I are continuously tracking these biotech and related stocks in a small discussion group.
Every day we exchange notes on what’s changing, what’s working, and where our original thesis may be breaking down.
This is not a paid service and not a signal group.
It’s simply a place to observe the market together, review decisions, and sharpen judgment over time.
If you’re also interested in biotech names especially lower-priced or undervalued companies with real catalysts feel free to leave a comment or send me a DM. I can share a group invite.
Not investment advice. This is purely for personal research discussion and market observation.